Senior Research Associate, Disease Biology
- Intellia Therapeutics
- Cambridge, MA
- Start date
- Mar 19, 2023
- Regulatory, Science/R&D, Biology, Pathology
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Genetown, Best Places to Work
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How you will Achieve More with Intellia:
We’re seeking a highly skilled and motivated Senior Research Associate to join our growing team. The primary responsibilities for this position will be to assist with (1) in vitro experiments in primary human cells (liver and bone marrow) and (2) perform molecular biology and flow cytometry assays in support of in vivo studies.
We’re looking for an experienced junior scientist to help us execute on Intellia’s gene editing programs. This position will be involved in the execution and interpretation of experiments, assist in experiments to assess nonviral delivery approaches to tissues, and optimize new protocols for engineering primary cells and cell lines. Furthermore, they will develop molecular biology detection and quantification techniques such as Western blot, ddPCR and ELISA and assist in tissue processing and sample preparation for FACS sorting and NGS. This role will involve conducting experiments independently and in collaboration with team members, must maintain highly detailed and up-to-date records of all experiments and communicate findings with internal and external partners.
Bachelor’s Degree in biologic sciences
Experience with hepatic and hematologic diseases
Knowledge of primary cell culture (such as thawing, cell expansion, cell counts, lot to lot comparison, media preparation)
Experience with molecular biology assays (such as DNA and RNA isolation, PCR, agarose gels, protein lysates)
Well-organized and capable of multitasking with overlapping experiments related to different projects
Demonstrated ability to think critically and creatively to solve scientific problems
Collaborative nature and flexibility to pitch in and help team members to deliver on commitments
Strong desire to learn new skills and biology related to new therapeutic areas
Excellent time management, communication, and presentation skills
Meet your future team:
The Disease Biology group is a highly engaged group of bright, fun, and team-first individuals with a spectrum of expertise ranging across biological diseases, assay development, in vivo modeling, translational research, and flow cytometry experts. You will report direction to the Associate Director of Liver Disease Biology who strives to foster the careers of early-career scientists in her group. Your future team is driven to change patients’ lives. As we build our team, we’re excited to work with people who share our commitment and energy to making a difference. Our team is currently working on site and much of the day-to-day operations requires wet-lab work. We are focused on building not just technical expertise but fostering an environment for the growth of scientists interested in a career in therapeutic biotechnology. If you join our team, you can expect to join a fast, exciting, and collaborative environment. We look forward to fostering your skills, learning from your experiences, and building a larger team together.
Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.
Change life stories with genome editing therapies!
Stock Symbol: NTLA
- (857) 285-6200
40 Erie Street
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.Create alert